Entera Bio (ENTX) Research & Development (2021 - 2026)
Entera Bio (ENTX) recorded quarterly Research & Development of $2.3 million in Q1 2026, up 31.02% on a QoQ basis from $1.7 million in Q4 2025, and up 100.45% year-over-year from $1.1 million in Q1 2025.
Entera Bio (ENTX) Research & Development (2021 - 2026) Analysis & Trends
Entera Bio has disclosed Research & Development across 6 years of filings, most recently posting $2.3 million for Q1 2026.
- Quarterly Research & Development rose 100.45% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (up 45.94% YoY) and the FY2025 annual result came in at $6.0 million, up 33.45% from the prior year.
- Research & Development improved to $2.3 million in Q1 2026, from $1.7 million in the prior quarter.
- Over five years, Research & Development peaked at $2.3 million in Q1 2026 and troughed at $735000.0 in Q1 2024.
- A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development sank 49.0% — and 2026, when it soared 100.45%.
- Tracing ENTX's Research & Development over 5 years: stood at $1.4 million in 2022, then declined by 25.98% to $1.0 million in 2023, then advanced by 20.1% to $1.2 million in 2024, then jumped by 43.05% to $1.7 million in 2025, then jumped by 31.02% to $2.3 million in 2026.
- Business Quant data shows ENTX's Research & Development at $2.3 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.23 Mn |